Clinical trials
Phase 1/2 Lymphoma, B-Cell trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Cancer Research UK | 2 |
| Celgene | 2 |
| Hoffmann-La Roche | 2 |
| Epizyme, Inc. | 1 |
| Gilead Sciences | 1 |
| Janssen Research & Development, LLC | 1 |
| Loxo Oncology, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 16 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Mantle-Cell | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma | 3 |
| Immune System Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Leukemia, B-Cell | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.